Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?

To date, more than 100 million people worldwide have recovered from COVID-19. Unfortunately, although the virus is eradicated in such patients, fibrotic irreversible interstitial lung disease (pulmonary fibrosis, PF) is clinically evident. Given the vast numbers of individuals affected, it is urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bari, Elia, Ferrarotti, Ilaria, Saracino, Laura, Perteghella, Sara, Torre, Maria Luisa, Richeldi, Luca, Corsico, Angelo Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155949/
https://www.ncbi.nlm.nih.gov/pubmed/34068958
http://dx.doi.org/10.3390/cells10051203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155949/
https://www.ncbi.nlm.nih.gov/pubmed/34068958
http://dx.doi.org/10.3390/cells10051203

Ejemplares similares